Yanai K - Search Results

1

Practical microscale one-pot radiosynthesis of ¹⁸ F-labeled probes.

Iwata R, Pascali C, Terasaki K, Ishikawa Y, Furumoto S, Yanai K. Iwata R, et al. Among authors: yanai k. J Labelled Comp Radiopharm. 2018 Jun 15;61(7):540-549. doi: 10.1002/jlcr.3618. Epub 2018 Apr 17. J Labelled Comp Radiopharm. 2018. PMID: 29520821

2

[18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent: preparation and application to the on-column preparation of [18F]fluorocholine.

Iwata R, Pascali C, Bogni A, Furumoto S, Terasaki K, Yanai K. Iwata R, et al. Among authors: yanai k. Appl Radiat Isot. 2002 Sep;57(3):347-52. doi: 10.1016/s0969-8043(02)00123-9. Appl Radiat Isot. 2002. PMID: 12201141

3

Evaluation of the binding characteristics of [5-(11)C-methoxy]Donepezil in the rat brain for in vivo visualization of acetylcholinesterase.

Funaki Y, Kato M, Iwata R, Sakurai E, Sakurai E, Tashiro M, Ido T, Yanai K. Funaki Y, et al. Among authors: yanai k. J Pharmacol Sci. 2003 Feb;91(2):105-12. doi: 10.1254/jphs.91.105. J Pharmacol Sci. 2003. PMID: 12686754 Free article.

4

Decreased histamine H1 receptor binding in the brain of depressed patients.

Kano M, Fukudo S, Tashiro A, Utsumi A, Tamura D, Itoh M, Iwata R, Tashiro M, Mochizuki H, Funaki Y, Kato M, Hongo M, Yanai K. Kano M, et al. Among authors: yanai k. Eur J Neurosci. 2004 Aug;20(3):803-10. doi: 10.1111/j.1460-9568.2004.03540.x. Eur J Neurosci. 2004. PMID: 15255990

5

Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.

Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K. Tashiro M, et al. Among authors: yanai k. J Clin Pharmacol. 2004 Aug;44(8):890-900. doi: 10.1177/0091270004267590. J Clin Pharmacol. 2004. PMID: 15286093 Clinical Trial.

6

Histamine H1 receptors in schizophrenic patients measured by positron emission tomography.

Iwabuchi K, Ito C, Tashiro M, Kato M, Kano M, Itoh M, Iwata R, Matsuoka H, Sato M, Yanai K. Iwabuchi K, et al. Among authors: yanai k. Eur Neuropsychopharmacol. 2005 Mar;15(2):185-91. doi: 10.1016/j.euroneuro.2004.10.001. Eur Neuropsychopharmacol. 2005. PMID: 15695063

7

Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.

Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H, Yamamoto T, Fujiwara H, Nemoto M, Maruyama M, Arai H, Yanai K, Sawada T, Kudo Y. Okamura N, et al. Among authors: yanai k. J Neurosci. 2005 Nov 23;25(47):10857-62. doi: 10.1523/JNEUROSCI.1738-05.2005. J Neurosci. 2005. PMID: 16306398 Free PMC article.

8

[Alzheimer' s disease].

Okamura N, Furumoto S, Kudo Y, Yanai K. Okamura N, et al. Among authors: yanai k. Nihon Rinsho. 2007 Feb;65(2):320-6. Nihon Rinsho. 2007. PMID: 17302278 Review. Japanese.

9

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H. Kudo Y, et al. Among authors: yanai k. J Nucl Med. 2007 Apr;48(4):553-61. doi: 10.2967/jnumed.106.037556. J Nucl Med. 2007. PMID: 17401091 Free article.

10

Recent advances in the development of amyloid imaging agents.

Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, Kudo Y. Furumoto S, et al. Among authors: yanai k. Curr Top Med Chem. 2007;7(18):1773-89. doi: 10.2174/156802607782507402. Curr Top Med Chem. 2007. PMID: 17979786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

528 results

Search Page